| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide alpha-N-acetyltransferase activity | 2.93e-06 | 8 | 76 | 3 | GO:0004596 | |
| GeneOntologyMolecularFunction | parathyroid hormone receptor activity | 1.43e-05 | 2 | 76 | 2 | GO:0004991 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.87e-05 | 14 | 76 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | transporter activity | SLC6A12 CLPTM1L GJA4 GJA5 CLCN3 PSG2 NOX5 ABCA13 ANO6 PSG11 SLC19A2 OTOP1 PSG8 SLC41A1 CNGA2 SLC38A8 | 2.25e-05 | 1289 | 76 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A12 GJA4 GJA5 CLCN3 PSG2 NOX5 ABCA13 ANO6 PSG11 SLC19A2 OTOP1 PSG8 SLC41A1 CNGA2 SLC38A8 | 3.22e-05 | 1180 | 76 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | GPI anchor binding | 8.88e-05 | 23 | 76 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.02e-04 | 196 | 76 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.38e-04 | 207 | 76 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.42e-04 | 208 | 76 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.54e-04 | 133 | 76 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | filamin binding | 1.80e-04 | 29 | 76 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.80e-04 | 29 | 76 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.95e-04 | 140 | 76 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.66e-04 | 33 | 76 | 3 | GO:0033764 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.91e-04 | 34 | 76 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 3.86e-04 | 90 | 76 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 3.94e-04 | 8 | 76 | 2 | GO:0047023 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 4.39e-04 | 39 | 76 | 3 | GO:0016229 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 5.06e-04 | 9 | 76 | 2 | GO:0047044 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | GSTT2 RDH16 NOX5 CYP11A1 HSD17B6 DHCR24 AGMO MDH1B GSTT2B NSDHL | 6.30e-04 | 766 | 76 | 10 | GO:0016491 |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 7.69e-04 | 11 | 76 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | glycolipid binding | 8.61e-04 | 49 | 76 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 8.77e-04 | 293 | 76 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 1.08e-03 | 53 | 76 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.41e-03 | 127 | 76 | 4 | GO:0016616 | |
| GeneOntologyMolecularFunction | glucosidase activity | 1.45e-03 | 15 | 76 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.55e-03 | 60 | 76 | 3 | GO:0034212 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 1.87e-03 | 17 | 76 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 1.91e-03 | 138 | 76 | 4 | GO:0016614 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.42e-03 | 70 | 76 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.72e-03 | 73 | 76 | 3 | GO:0170055 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 3.28e-03 | 78 | 76 | 3 | GO:0008080 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 3.43e-03 | 23 | 76 | 2 | GO:0017128 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 3.74e-03 | 24 | 76 | 2 | GO:0004745 | |
| GeneOntologyMolecularFunction | channel activity | 3.82e-03 | 525 | 76 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 3.86e-03 | 526 | 76 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | gap junction channel activity | 4.05e-03 | 25 | 76 | 2 | GO:0005243 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 4.30e-03 | 173 | 76 | 4 | GO:0070851 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 4.38e-03 | 26 | 76 | 2 | GO:0004022 | |
| GeneOntologyMolecularFunction | proton channel activity | 4.72e-03 | 27 | 76 | 2 | GO:0015252 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 4.84e-03 | 288 | 76 | 5 | GO:0016757 | |
| GeneOntologyMolecularFunction | glutathione peroxidase activity | 5.07e-03 | 28 | 76 | 2 | GO:0004602 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 5.43e-03 | 29 | 76 | 2 | GO:0004364 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 5.80e-03 | 30 | 76 | 2 | GO:0018455 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 6.27e-03 | 884 | 76 | 9 | GO:0004930 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 6.95e-03 | 102 | 76 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 7.33e-03 | 104 | 76 | 3 | GO:0016407 | |
| GeneOntologyMolecularFunction | wide pore channel activity | 8.74e-03 | 37 | 76 | 2 | GO:0022829 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.70e-05 | 14 | 76 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 2.12e-05 | 15 | 76 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 2.12e-05 | 15 | 76 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 2.12e-05 | 15 | 76 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.12e-05 | 15 | 76 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 2.60e-05 | 16 | 76 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 2.60e-05 | 16 | 76 | 3 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 2.80e-05 | 96 | 76 | 5 | GO:0050818 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 3.15e-05 | 17 | 76 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 3.15e-05 | 17 | 76 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 3.15e-05 | 17 | 76 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 3.77e-05 | 18 | 76 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 5.24e-05 | 20 | 76 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 6.10e-05 | 21 | 76 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 6.10e-05 | 21 | 76 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 6.10e-05 | 21 | 76 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 7.04e-05 | 22 | 76 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 7.57e-05 | 61 | 76 | 4 | GO:0060259 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 8.07e-05 | 23 | 76 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 8.07e-05 | 23 | 76 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 9.20e-05 | 24 | 76 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 9.20e-05 | 24 | 76 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 9.20e-05 | 24 | 76 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 1.04e-04 | 25 | 76 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.04e-04 | 25 | 76 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 1.10e-04 | 128 | 76 | 5 | GO:0050795 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.32e-04 | 27 | 76 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.45e-04 | 72 | 76 | 4 | GO:0050819 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.47e-04 | 28 | 76 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.64e-04 | 29 | 76 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 1.64e-04 | 29 | 76 | 3 | GO:0031365 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | CDS1 RDH16 PSG2 CYP11A1 PSG11 HSD17B6 DHCR24 AGMO ST8SIA5 PSG8 NSDHL | 1.84e-04 | 813 | 76 | 11 | GO:0008610 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 2.01e-04 | 31 | 76 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 2.20e-04 | 442 | 76 | 8 | GO:0050878 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 2.21e-04 | 32 | 76 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 2.21e-04 | 32 | 76 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 2.21e-04 | 32 | 76 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 2.30e-04 | 334 | 76 | 7 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 2.30e-04 | 334 | 76 | 7 | GO:0001894 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 2.42e-04 | 33 | 76 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 2.42e-04 | 33 | 76 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.65e-04 | 34 | 76 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 2.65e-04 | 34 | 76 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-methionine acetylation | 2.78e-04 | 7 | 76 | 2 | GO:0017196 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.89e-04 | 35 | 76 | 3 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 3.57e-04 | 91 | 76 | 4 | GO:0030193 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 3.70e-04 | 38 | 76 | 3 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of cell volume | 3.70e-04 | 8 | 76 | 2 | GO:0045794 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 3.88e-04 | 93 | 76 | 4 | GO:1900046 | |
| GeneOntologyBiologicalProcess | blood coagulation | 3.96e-04 | 260 | 76 | 6 | GO:0007596 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 3.99e-04 | 39 | 76 | 3 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 4.31e-04 | 40 | 76 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | coagulation | 4.47e-04 | 266 | 76 | 6 | GO:0050817 | |
| GeneOntologyBiologicalProcess | wound healing | 4.57e-04 | 493 | 76 | 8 | GO:0042060 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 4.63e-04 | 41 | 76 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | hemostasis | 4.65e-04 | 268 | 76 | 6 | GO:0007599 | |
| GeneOntologyBiologicalProcess | bone resorption | 4.92e-04 | 99 | 76 | 4 | GO:0045453 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 4.98e-04 | 42 | 76 | 3 | GO:0090330 | |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 4.98e-04 | 42 | 76 | 3 | GO:0006884 | |
| GeneOntologyBiologicalProcess | endothelium development | 5.64e-04 | 182 | 76 | 5 | GO:0003158 | |
| GeneOntologyBiologicalProcess | ketone metabolic process | 5.74e-04 | 279 | 76 | 6 | GO:0042180 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 6.10e-04 | 45 | 76 | 3 | GO:0048521 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 6.14e-04 | 105 | 76 | 4 | GO:0042267 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 6.51e-04 | 46 | 76 | 3 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 6.51e-04 | 46 | 76 | 3 | GO:0072574 | |
| GeneOntologyBiologicalProcess | protein acylation | 6.83e-04 | 108 | 76 | 4 | GO:0043543 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 6.94e-04 | 47 | 76 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 6.94e-04 | 47 | 76 | 3 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 6.94e-04 | 47 | 76 | 3 | GO:0034104 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 7.07e-04 | 109 | 76 | 4 | GO:0002228 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 7.84e-04 | 49 | 76 | 3 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 7.84e-04 | 49 | 76 | 3 | GO:0002837 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 8.06e-04 | 412 | 76 | 7 | GO:0006066 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 8.32e-04 | 50 | 76 | 3 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 8.36e-04 | 114 | 76 | 4 | GO:0045824 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 9.33e-04 | 52 | 76 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | sexual reproduction | CFAP47 NOX5 USP9X MROH2B KIAA0319L HASPIN SLC19A2 PIWIL4 HERC2 CATSPERG TUBGCP5 PAQR7 B4GALT1 | 9.40e-04 | 1312 | 76 | 13 | GO:0019953 |
| GeneOntologyBiologicalProcess | vasculogenesis | 9.51e-04 | 118 | 76 | 4 | GO:0001570 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 9.87e-04 | 53 | 76 | 3 | GO:0034110 | |
| GeneOntologyBiologicalProcess | peptidyl-methionine modification | 1.02e-03 | 13 | 76 | 2 | GO:0018206 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.16e-03 | 56 | 76 | 3 | GO:0002418 | |
| GeneOntologyBiologicalProcess | bone remodeling | 1.25e-03 | 127 | 76 | 4 | GO:0046849 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | CFAP47 NOX5 CYP11A1 USP9X MROH2B KIAA0319L SLC19A2 PIWIL4 HERC2 CATSPERG PAQR7 B4GALT1 | 1.33e-03 | 1194 | 76 | 12 | GO:0048609 |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.35e-03 | 59 | 76 | 3 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 1.41e-03 | 60 | 76 | 3 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 1.41e-03 | 60 | 76 | 3 | GO:0045922 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 1.48e-03 | 133 | 76 | 4 | GO:0006766 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation | 1.48e-03 | 226 | 76 | 5 | GO:0050680 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 1.74e-03 | 139 | 76 | 4 | GO:0007173 | |
| GeneOntologyBiologicalProcess | bone mineralization involved in bone maturation | 1.76e-03 | 17 | 76 | 2 | GO:0035630 | |
| GeneOntologyBiologicalProcess | N-glycan processing | 1.76e-03 | 17 | 76 | 2 | GO:0006491 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 1.78e-03 | 65 | 76 | 3 | GO:0097035 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.86e-03 | 66 | 76 | 3 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 1.94e-03 | 67 | 76 | 3 | GO:0045601 | |
| GeneOntologyBiologicalProcess | protein acetylation | 2.03e-03 | 68 | 76 | 3 | GO:0006473 | |
| GeneOntologyBiologicalProcess | blood vessel development | 2.11e-03 | 929 | 76 | 10 | GO:0001568 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 2.12e-03 | 69 | 76 | 3 | GO:0030195 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 2.15e-03 | 246 | 76 | 5 | GO:0045216 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 2.20e-03 | 70 | 76 | 3 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 2.20e-03 | 70 | 76 | 3 | GO:1900047 | |
| GeneOntologyCellularComponent | N-terminal protein acetyltransferase complex | 5.66e-06 | 10 | 77 | 3 | GO:0031414 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 2.60e-05 | 16 | 77 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.77e-04 | 320 | 77 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.86e-04 | 431 | 77 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | basal plasma membrane | 3.28e-04 | 354 | 77 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | ciliary membrane | 4.73e-04 | 98 | 77 | 4 | GO:0060170 | |
| GeneOntologyCellularComponent | basal part of cell | 4.85e-04 | 378 | 77 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | cilium | CFAP47 PSG2 USP9X PSG11 MROH2B PSG8 TACR3 IFT80 CATSPERG CNGA2 | 1.65e-03 | 898 | 77 | 10 | GO:0005929 |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 4.20e-05 | 17 | 57 | 3 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 8.11e-05 | 21 | 57 | 3 | MP:0031415 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 1.02e-04 | 60 | 57 | 4 | MP:0009790 | |
| MousePheno | decreased fatty acid oxidation | 1.22e-04 | 24 | 57 | 3 | MP:0014172 | |
| MousePheno | decreased susceptibility to viral infection | 1.52e-04 | 125 | 57 | 5 | MP:0002410 | |
| MousePheno | increased abdominal fat pad weight | 1.75e-04 | 27 | 57 | 3 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 1.96e-04 | 28 | 57 | 3 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 2.66e-04 | 31 | 57 | 3 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 2.66e-04 | 31 | 57 | 3 | MP:0008964 | |
| Domain | Acetyltransf_1 | 9.99e-05 | 23 | 74 | 3 | PF00583 | |
| Domain | GNAT | 1.29e-04 | 25 | 74 | 3 | PS51186 | |
| Domain | GNAT_dom | 1.29e-04 | 25 | 74 | 3 | IPR000182 | |
| Domain | - | 5.31e-04 | 40 | 74 | 3 | 3.40.630.30 | |
| Domain | Acyl_CoA_acyltransferase | 7.52e-04 | 45 | 74 | 3 | IPR016181 | |
| Domain | CONNEXINS_1 | 2.54e-03 | 19 | 74 | 2 | PS00407 | |
| Domain | CONNEXINS_2 | 2.81e-03 | 20 | 74 | 2 | PS00408 | |
| Domain | Connexin | 2.81e-03 | 20 | 74 | 2 | IPR000500 | |
| Domain | Connexin_CCC | 2.81e-03 | 20 | 74 | 2 | IPR019570 | |
| Domain | Connexin_N | 2.81e-03 | 20 | 74 | 2 | IPR013092 | |
| Domain | Connexin | 2.81e-03 | 20 | 74 | 2 | PF00029 | |
| Domain | Connexin_CCC | 2.81e-03 | 20 | 74 | 2 | SM01089 | |
| Domain | Connexin_CS | 2.81e-03 | 20 | 74 | 2 | IPR017990 | |
| Domain | CNX | 2.81e-03 | 20 | 74 | 2 | SM00037 | |
| Domain | Ig_2 | 3.04e-03 | 73 | 74 | 3 | PF13895 | |
| Domain | GST_N | 3.40e-03 | 22 | 74 | 2 | PF02798 | |
| Domain | GST_NTER | 3.40e-03 | 22 | 74 | 2 | PS50404 | |
| Domain | HormR | 4.38e-03 | 25 | 74 | 2 | SM00008 | |
| Domain | - | 4.55e-03 | 169 | 74 | 4 | 3.40.50.720 | |
| Domain | GST_C | 4.73e-03 | 26 | 74 | 2 | IPR004046 | |
| Domain | GST_C | 4.73e-03 | 26 | 74 | 2 | PF00043 | |
| Domain | NAD(P)-bd_dom | 4.94e-03 | 173 | 74 | 4 | IPR016040 | |
| Domain | Glutathione_S-Trfase_N | 5.10e-03 | 27 | 74 | 2 | IPR004045 | |
| Domain | HRM | 5.48e-03 | 28 | 74 | 2 | PF02793 | |
| Domain | GST_CTER | 8.00e-03 | 34 | 74 | 2 | PS50405 | |
| Domain | GPCR_2_secretin-like_CS | 8.00e-03 | 34 | 74 | 2 | IPR017983 | |
| Domain | Sc_DH/Rdtase_CS | 8.47e-03 | 35 | 74 | 2 | IPR020904 | |
| Domain | Glutathione-S-Trfase_C-like | 1.04e-02 | 39 | 74 | 2 | IPR010987 | |
| Domain | - | 1.04e-02 | 39 | 74 | 2 | 1.20.1050.10 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.10e-02 | 40 | 74 | 2 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 1.10e-02 | 40 | 74 | 2 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.10e-02 | 40 | 74 | 2 | PS50227 | |
| Pubmed | A synopsis of eukaryotic Nalpha-terminal acetyltransferases: nomenclature, subunits and substrates. | 2.35e-06 | 12 | 78 | 3 | 19660095 | |
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 3.05e-06 | 13 | 78 | 3 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 3.05e-06 | 13 | 78 | 3 | 1985902 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 15207636 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 19285068 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 21760897 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 1719235 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 10964771 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 3.05e-06 | 13 | 78 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 3.05e-06 | 13 | 78 | 3 | 16638824 | |
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 3.05e-06 | 13 | 78 | 3 | 1326665 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 20044046 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 32150576 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 21081647 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 3.05e-06 | 13 | 78 | 3 | 39168268 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 22469976 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 11483763 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 3.05e-06 | 13 | 78 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 3.05e-06 | 13 | 78 | 3 | 28035001 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 3.05e-06 | 13 | 78 | 3 | 12832451 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 3.05e-06 | 13 | 78 | 3 | 15316023 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 8402684 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 3.05e-06 | 13 | 78 | 3 | 21670291 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 22162753 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 2164599 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 3.05e-06 | 13 | 78 | 3 | 23935487 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 2702644 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 16619040 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 8380065 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 1279194 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 15331748 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 3.05e-06 | 13 | 78 | 3 | 8209741 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 3.05e-06 | 13 | 78 | 3 | 22406619 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 3.05e-06 | 13 | 78 | 3 | 21949477 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 29396368 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 26219866 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 7628460 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 25724769 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 18003729 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 26284027 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 2133556 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 32521208 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 26374765 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 3.05e-06 | 13 | 78 | 3 | 33352461 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 19406938 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 38381498 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 20739537 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 19621080 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 3.05e-06 | 13 | 78 | 3 | 25972571 | |
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 3.05e-06 | 13 | 78 | 3 | 29967450 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 1633107 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 3.05e-06 | 13 | 78 | 3 | 19358828 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 3.05e-06 | 13 | 78 | 3 | 27695943 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 20404914 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 3.05e-06 | 13 | 78 | 3 | 22092845 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 16680193 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 11801635 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 26911181 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 1653760 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 28913658 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 3.05e-06 | 13 | 78 | 3 | 32027621 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 19008452 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 18544705 | ||
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 3.05e-06 | 13 | 78 | 3 | 27777319 | |
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 3.05e-06 | 13 | 78 | 3 | 15220458 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 18848945 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 3.05e-06 | 13 | 78 | 3 | 8500759 | |
| Pubmed | 3.05e-06 | 13 | 78 | 3 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 3.05e-06 | 13 | 78 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 3.05e-06 | 13 | 78 | 3 | 23800882 | |
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 37531413 | ||
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 23780386 | ||
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 28567513 | ||
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 8207827 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 3.88e-06 | 14 | 78 | 3 | 26196244 | |
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 3.88e-06 | 14 | 78 | 3 | 34666041 | |
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 8896983 | ||
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 19700760 | ||
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 34619794 | ||
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 22962327 | ||
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 17623671 | ||
| Pubmed | Loss of CEACAM1 in endothelial cells causes hepatic fibrosis. | 3.88e-06 | 14 | 78 | 3 | 37088122 | |
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 26846848 | ||
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 14517298 | ||
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 23070997 | ||
| Pubmed | Expression patterns of CD66a and CD117 in the mouse submandibular gland. | 3.88e-06 | 14 | 78 | 3 | 25498293 | |
| Pubmed | Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling. | 3.88e-06 | 14 | 78 | 3 | 29746166 | |
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 9212243 | ||
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 25908210 | ||
| Pubmed | 3.88e-06 | 14 | 78 | 3 | 9047385 | ||
| Pubmed | Ceacam1L Modulates STAT3 Signaling to Control the Proliferation of Glioblastoma-Initiating Cells. | 3.88e-06 | 14 | 78 | 3 | 26238781 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 5.35e-06 | 11 | 59 | 3 | 1315 | |
| GeneFamily | N(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases | 7.11e-06 | 12 | 59 | 3 | 660 | |
| GeneFamily | Parathyroid hormone receptors | 1.05e-05 | 2 | 59 | 2 | 270 | |
| GeneFamily | GCN5 related N-acetyltransferases | 6.36e-05 | 24 | 59 | 3 | 1134 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 1.96e-03 | 76 | 59 | 3 | 743 | |
| GeneFamily | Gap junction proteins | 2.32e-03 | 22 | 59 | 2 | 314 | |
| GeneFamily | Glutathione S-transferases | 2.99e-03 | 25 | 59 | 2 | 567 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 2.64e-06 | 75 | 76 | 5 | MM605 | |
| Coexpression | GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN | 2.16e-05 | 194 | 76 | 6 | M4683 | |
| Disease | Charcot-Marie-Tooth disease (biomarker_via_orthology) | 6.20e-06 | 2 | 74 | 2 | DOID:10595 (biomarker_via_orthology) | |
| Disease | D dimer measurement | 5.85e-05 | 30 | 74 | 3 | EFO_0004507 | |
| Disease | paraxanthine measurement | 4.03e-04 | 12 | 74 | 2 | EFO_0021178 | |
| Disease | 3-formylindole measurement | 4.75e-04 | 13 | 74 | 2 | EFO_0801025 | |
| Disease | malignant pleural mesothelioma (is_marker_for) | 5.54e-04 | 14 | 74 | 2 | DOID:7474 (is_marker_for) | |
| Disease | cD177 antigen measurement | 9.25e-04 | 18 | 74 | 2 | EFO_0021866 | |
| Disease | Disproportionate short stature | 9.69e-04 | 77 | 74 | 3 | C0878659 | |
| Disease | CCL4 measurement | 1.14e-03 | 20 | 74 | 2 | EFO_0004751 | |
| Disease | prothrombin time measurement | 1.26e-03 | 21 | 74 | 2 | EFO_0008390 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IYQGLVYYLLWLHSV | 681 | Q6ZRH7 | |
| VYYLLWLHSVYDKPY | 686 | Q6ZRH7 | |
| LQISYFRDPYHVWYQ | 31 | Q9UNN8 | |
| NRQEHLKYWLYYLHP | 186 | P15291 | |
| LKYWLYYLHPVLQRQ | 191 | P15291 | |
| YRVYHSYDLPWFRTL | 131 | Q92903 | |
| SYIYIWENYRLFNLP | 96 | Q6ZNB7 | |
| WEHLYYYCSLRGIPR | 4816 | Q86UQ4 | |
| YIWDVTILEYLTYLH | 931 | Q75QN2 | |
| YLYLNIPTIARYEWH | 476 | Q96PH1 | |
| YLLYREWAHPRSIYK | 266 | Q4KMQ2 | |
| FHLYPEVIIAAWYRT | 186 | Q6NXN4 | |
| YIYAGYRPLHQTWRF | 46 | Q86WK9 | |
| KWYAHQLQPIHYRVY | 581 | Q8WXG6 | |
| PFLWRAALLYYTVYQ | 381 | Q8NCT3 | |
| YVICWLPYHARRLMY | 306 | O95665 | |
| GTYWVRYIHVELIGY | 2616 | O95714 | |
| TYTYDWQLITHPRDY | 341 | Q8IZA0 | |
| YTFTYRYLHWVRQAP | 46 | A0A0A0MS14 | |
| PNSVLPLYYRYWVHS | 656 | P50747 | |
| FYLQYLAHWPEYFIV | 31 | P61599 | |
| YSQIWILYPIICTYH | 266 | A6NMU1 | |
| NLYPEVILASWYRIY | 106 | Q2PZI1 | |
| PVNHRDFWYATYTLY | 501 | Q96RT8 | |
| YWLSRNLLWYIPHYF | 236 | Q86SM8 | |
| YDRYAAIWNPLLYPV | 126 | Q8NGF4 | |
| LIYLSCKYQTPDHWY | 71 | P0CG30 | |
| EGHPRYTWYNLPYSI | 416 | Q7RTM1 | |
| YTWYNLPYSILAIVE | 421 | Q7RTM1 | |
| VWYYPNTVYVDRDIL | 531 | Q9P2H3 | |
| AAFVGLYYLLHWYRE | 6 | O14756 | |
| YQLLLDTRYEPYIKW | 231 | Q9Y603 | |
| AFYHALYPRAWTVYQ | 226 | Q9HCG7 | |
| NYHYLVKWRDLPYDQ | 646 | Q12873 | |
| PLSLIFDIYYYVRAW | 41 | Q15392 | |
| YDQAFPISHIRYWVL | 66 | P36382 | |
| CWLPNHVIYLYRSYH | 276 | P30550 | |
| LIYLSCKYQTPDHWY | 71 | P0CG29 | |
| FLIPPWVAYHQYYQR | 121 | P05108 | |
| THDRAVWYDPIYYPT | 2931 | Q99698 | |
| RVYRYESAIWGPLHY | 326 | Q5I0G3 | |
| YHPYSNVLWLHYLTD | 736 | Q8TF76 | |
| PSTFYPWLIHRYRYL | 116 | Q04743 | |
| YDQAFPISHIRYWVL | 66 | P35212 | |
| IWYKGQIRDLYHYIT | 66 | Q9UQ72 | |
| STPYRQWYESHYALP | 106 | P62241 | |
| NEIYPVWTYSYLVLL | 71 | O60779 | |
| YPYKEILYLIHVRPW | 2461 | Q6ZTR5 | |
| HYRIFRLPNNWYYIS | 131 | Q13239 | |
| LLWQVAYSYTYELRP | 2321 | Q93008 | |
| IRVYLLQGWYIVTYA | 56 | O15258 | |
| SEYYLIHVLGTLWYL | 176 | Q9NYW6 | |
| AVFVGLYYLLHWYRE | 6 | O75452 | |
| IWYKGQIRDLYHYIT | 66 | Q9UQ74 | |
| SLLPFWYTLLYQAHR | 706 | Q14697 | |
| ESYLNVYYIIILAWA | 126 | P48065 | |
| WQLYQYHVTYIPDLA | 121 | Q7Z3Z4 | |
| SPVYRRYKHFDWLYN | 261 | Q8WV41 | |
| YFHPQYLVNVSRYWL | 276 | O15466 | |
| GLYLELNHWRYIYPL | 276 | Q8IVJ1 | |
| LNYEAPKYHIPYWVA | 286 | Q15738 | |
| YLALVITVQYYLWPQ | 186 | A6NNN8 | |
| YRVIALQYPVYWDHL | 71 | Q9NZD8 | |
| AIYKYVNHWRDFPYP | 161 | Q7Z745 | |
| CWLPYHIYFILTAIY | 311 | P29371 | |
| WLYLHRYNAYPSEQE | 36 | Q9GZN2 | |
| QTPAHVYYRWKLYSI | 466 | O15042 | |
| VVFLVYLYQRWLYPV | 501 | Q96KA5 | |
| YILVIIHWNACIYYA | 281 | Q16280 | |
| NSRLVLFYVEYHTPW | 371 | P51790 | |
| LFYVEYHTPWYLFEL | 376 | P51790 | |
| YLYHGLSWPQLSYIA | 31 | Q9BSU3 | |
| YYWILVEGLYLHSLI | 296 | Q03431 | |
| QIHWTPYRAMYQYRP | 611 | O60504 | |
| LLYYCYHDLEDPQWI | 171 | Q5T7W7 | |
| YYWILVEGLYLHNLI | 251 | P49190 | |
| YYYHVITRQTQWDPP | 2406 | Q9BYW2 | |
| PVLALWYYYLTHRRK | 121 | Q8IYP9 | |
| IWYKGQIRDLYHYIT | 66 | P11465 | |
| YNSEYYHFRQAWVPL | 956 | Q13308 | |
| RYDPISGHNALYWYR | 41 | A0A0A6YYK4 | |
| YPWRQNAHRYYIHLL | 96 | A0A1B0GTI8 | |
| IYTYRYFIHNWPQLC | 241 | Q147X3 |